Stage III Grade 3 Follicular Lymphoma Completed Phase 0 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00017381Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's LymphomaTreatment